Concepedia

Rebecca L. Conklin

RL

8

Publications

548

Citations

8

H-Index

1995

Active since

Affiliations

Arrien Pharmaceuticals (United States)(Current)

Drug Discovery Laboratory (Norway)

Rebecca L. Conklin is an author at Arrien Pharmaceuticals (United States) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1995–2005

8

Publications

8

Calcilytic Compounds: Potent and Selective Ca2+Receptor Antagonists That Stimulate Secretion of Parathyroid Hormone

Edward F. Nemeth, Eric G. DelMar, William L. Heaton et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 233 citations

Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3.

Kimberly Rogers, Christine Dunn, Rebecca L. Conklin et al. · Endocrinology · 1995 · 83 citations

, , +20

Calcimimetic Compound NPS R-568 Stimulates Calcitonin Secretion But Selectively Targets Parathyroid Gland Ca2+ Receptor in Rats

John Fox, Stacey H. Lowe, Rebecca L. Conklin et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 76 citations

The Calcimimetic NPS R-568 Decreases Plasma PTH in Rats with Mild and Severe Renal or Dietary Secondary Hyperparathyroidism

John Fox, Stacey H. Lowe, Rebecca L. Conklin et al. · Endocrine · 1999 · 50 citations

, , +10

3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis

I. M. Shcherbakova, Manuel F. Balandrin, John Fox et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 47 citations · Full text

, , +8

Rows per page

1–5 of 8